The trials size, the fact that it was open-label, single-arm, not peer-reviewed or even published, and commissioned by the company
"They also act on your brain as well, where it controls your appetite, sexual function and a lot of things to do with your emotional decision making
The global Obesity Medicines market reached $66 billion in list price sales value in 2025, according to IQVIAs ForecastLink, and is forecast to rise to $92 billion in 2026, before reaching between $105 billion and $200 billion by 2027 and beyond
Additionally, concomitant use with other GLP-1 receptor agonists is not recommended
# MOTS-C vs GHK-Cu for Muscle Building Over 50: Which Peptide Should You Choose